| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |